Status:
UNKNOWN
Analgesic Efficacy of Adding SCB With Low Concentration Bupivacaine Combined With Dexamethasone on Pain After TKA
Lead Sponsor:
Mahidol University
Conditions:
Total Knee Arthroplasty
Adductor Canal Block
Eligibility:
All Genders
50-85 years
Phase:
PHASE4
Brief Summary
This study evaluate the efficacy of adding popliteal sciatic nerve block with low concentration bupivacaine and dexamethasone to abductor canal block for total knee arthroplasty in patient with NSAIDs...
Detailed Description
After informed and consent, all patients will be devided into two groups, Sciatic group (group S) and Controlled group (group C). All patients will receive adductor canal block, then patients in group...
Eligibility Criteria
Inclusion
- patient scheduled for single total knee arthroplasty
- patient with NSAIDs prescribing precautions such as history of NSAIDs allergy, Chronic kidney disease (GFR\< 50 ml/min), history of ischemic heart disease or cerebrovascular disease
Exclusion
- patient refusal
- body weight less than 45 kg
- history of allergy to bupivacaine or dexamethasone
- uncontrolled diabetes mellitus
- contraindicated for spinal block, adductor canal block or sciatic nerve block
- inability to assess pain score (cognitive or psychiatric history)
- patient scheduled for revision TKA
- preexisting neuropathy or neurological deficit in lower extremity
- preexisting chronic pain (prolonged use of oral morphine 20 mg/day or equivalent)
Key Trial Info
Start Date :
April 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2019
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03486548
Start Date
April 1 2018
End Date
February 1 2019
Last Update
April 3 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Siriraj Hospital, Mahidol University
Bangkoknoi, Bangkok, Thailand, 10700